Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly-Reference-Cited by-同舟云学术

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly

Published:2019-03-01 Issue:4 Volume:6 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Frey Sharon E¹,Shakib Sepehr²,Chanthavanich Pornthep³,Richmond Peter⁴,Smith Timothy⁵,Tantawichien Terapong⁶,Kittel Claudia⁷,Jaehnig Peter⁷,Mojares Zenaida⁸,Verma Bikash⁹,Kanesa-thasan Niranjan⁹,Hohenboken Matthew¹⁰

Affiliation:

1. School of Medicine, Saint Louis University, St. Louis, Missouri

2. CMAX Clinical Research Pty Ltd., Adelaide, SA, Australia

3. Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

4. Division of Paediatrics, School of Medicine, University of Western Australia, and Vaccine Trials Group, Telethon Kids Institute, Subiaco, WA, Australia

5. Mercy Health Research, St. Louis, Missouri

6. Department of Medicine, Faculty of Medicine, Chulalongkorn University and Queen Saovabha Memorial Institute, Bangkok, Thailand

7. GlaxoSmithKline Vaccines GmbH, Marburg, Germany

8. GlaxoSmithKline Pte Ltd., Singapore, Singapore

9. GlaxoSmithKline Vaccines LLC, Rockville, Maryland

10. Seqirus Inc., Cambridge, Massachusetts

Funder

Novartis Vaccines and Diagnostics Inc

US Office of Public Health Emergency Preparedness

Office of Research and Development Coordination

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/6/4/ofz107/28267069/ofz107.pdf

Reference28 articles.

1. World Health Organization. Avian influenza fact sheet. 2014. http://www.who.int/mediacentre/factsheets/avian_influenza/en/. Accessed November 2015.

2. Recognizing true H5N1 infections in humans during confirmed outbreaks;Zaman;J Infect Dev Ctries,2014

3. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2015. 2015. http://www.who.int/influenza/human_animal_interface/EN_GIP_20150106 CumulativeNumberH5N1cases.pdf?ua=1. Accessed November 2015.

4. World Health Organization. Pandemic influenza risk management WHO interim guidance June 2013. 2013. http://www.who.int/influenza/preparedness/pandemic/GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013.pdf?ua=1. Accessed November 2015.

5. Influenza: options to improve pandemic preparation;Rappuoli;Science,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study;Vaccines;2024-09-10

2. Pandemic preparedness through vaccine development for avian influenza viruses;Human Vaccines & Immunotherapeutics;2024-05-28

3. Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions;Vaccines;2024-04-30

4. Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults;Human Vaccines & Immunotherapeutics;2023-01-02

5. mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics;Vaccines;2022-12-15